Back

Copper chelation in hypertrophic cardiomyopathy; open-label pilot study assessing the effects of trientine on lv mass, myocardial fibrosis, performance and metabolism.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Cardiomyopathy Cardiomyopathies ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Anna Reid

Manchester University NHS Foundation Trust, Manchester (United Kingdom of Great Britain & Northern Ireland)

26 More presentations in this session

Presentation thumbnail
Sleep apnea diagnosis by using polysomnography may improve individual risk stratification in patients with hypertrophic cardiomyopathy
Associate Professor T. Kara (Rochester, US)
Abstract
Presentation thumbnail
Myocardial bridging in patients with apical hypertrophic cardiomyopathy
Doctor S. Zhai (Beijing, CN)
Abstract Slides
Presentation thumbnail
Accuracy of LGE-CMR compared with histometric quantification of myocardial fibrosis in transplanted hearts of end-stage HCM
Doctor G. Galati (Milan, IT)
Presentation thumbnail
Prevalence and progression of late gadolinium enhancement in children and adolescents with hypertrophic cardiomyopathy - a longitudinal study
Doctor A. Axelsson Raja (Copenhagen, DK)
Abstract
Presentation thumbnail
Prognostic role of myocardial edema at cardiac magnetic resonance in hypertrophic cardiomyopathy.
Doctor G. Todiere (Pisa, IT)
Abstract

Access the full session

Session thumbnail
Poster session 5 - Cardiomyopathy

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources